Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey

被引:10
|
作者
Kaur, Sukhpal [1 ]
Singh, Ajay [2 ]
Saini, Sushma [1 ]
Rohilla, Latika [1 ]
Kaur, Jasvir [1 ]
Chandi, Anadeep [3 ]
Kaur, Gurpreet [1 ]
Singh, Manjeet [9 ]
Kumar, Pramod [1 ]
Soni, Shiv Lal [10 ]
Kajal, Kamal [2 ]
Naik, Naveen B. [2 ]
Malhotra, Pankaj [4 ]
Verma, Sanjay [5 ]
Gupta, Madhu [6 ]
Devnani, Mahesh [7 ]
Das, Karobi [1 ]
Pandav, S. S. [8 ]
Puri, G. D. [2 ]
机构
[1] Govt Multispecial Hosp, Natl Inst Nursing Educ, Dept Nursing, Chandigarh, India
[2] Govt Multispecial Hosp, Dept Anaesthesia & Intens Care, Chandigarh, India
[3] Govt Multispecial Hosp, Dept Obstet & Gynaecol, Chandigarh, India
[4] Govt Multispecial Hosp, Dept Internal Med, Chandigarh, India
[5] Govt Multispecial Hosp, Dept Paediat, Chandigarh, India
[6] Govt Multispecial Hosp, Dept Community Med, Chandigarh, India
[7] Govt Multispecial Hosp, Hosp Adm, Chandigarh, India
[8] Multispecial Hosp, Postgrad Inst Med Educ & Res, Ophthalmol, Chandigarh, India
[9] Govt Multispecial Hosp, Dept Med, Chandigarh, India
[10] Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India
关键词
Adverse events; ChAdOx1; nCoV-19; coronavirus disease 2019; healthcare professionals; side effects; vaccination;
D O I
10.4103/ijmr.ijmr_1221_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The safety of the ChAdOx1 nCoV-19 vaccine is a cause of concern for many who have been vaccinated. The people have multiple concerns and fear regarding the adverse events of the vaccine. Thus, this study was undertaken to establish the safety profile of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) among the healthcare professionals. Methods: This was a descriptive cross-sectional survey. After taking clearance from the institutional ethics committee 1500 healthcare professionals, who had their vaccination in the past two weeks were selected. They were provided with an online survey proforma regarding adverse events following immunization (AEFIs) of COVID-19 vaccine developed using google forms with an informed consent form affixed to it. Results: A total of 1036 individuals participated in the study. The mean and median (inter quartile range) age of the participants was 37.7 +/- 11.25 and 35 (29-46) yr, respectively. Of these, 52.1 per cent were female, 29.3 per cent were doctors, 33.4 per cent were nurses and 9.5 per cent were paramedical staff. Forty six per cent participants experienced one or more minor AEFIs such as pain, tenderness, redness, etc. at the injection site. Fatigue (31.75%), generalized feeling of unwell (28.57%), muscle pain (23.16%) and fever (21.71%) were the most commonly reported systemic AEFIs followed by headache (20.07%), dizziness (10.03%) and joint pains (15.25%). Most of them experienced these AEFIs within 24 h of the first dose of administration. About 42 per cent of the participants took oral antipyretics/analgesics for managing the AEFIs. Interpretation & conclusions: ChAdOx1 nCoV-19 Corona Virus Vaccine was found to be associated with mild local and systemic AEFIs that were more common after the first dose as compared to the second dose. There adverse events could be dealt with oral over-the-counter medications, with no requirement of hospitalization.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [41] Safety of ChAdOx1 nCoV-19 Vaccine: Analysis of Adverse Reactions of COVID-19 AstraZeneca Vaccine Observed in a University Hospital in Morocco
    Tebaa, A.
    Moukafih, B.
    Leila, B.
    Soulaymani-Bencheikh, R.
    El Kartouti, A.
    Achour, S.
    DRUG SAFETY, 2021, 44 (12) : 1415 - 1416
  • [42] Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre
    Desai, Anuja
    Desai, Parth
    Mehta, Jigar
    Sachora, Wasimahmed
    Bharti, Neeraj
    Patel, Tushar
    Sukhwani, Kalpesh
    Jain, Ankita
    Sorathiya, Dipesh
    Nanda, Vivek
    Mehta, Parin
    Desai, Adit
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 282 - 287
  • [43] Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey
    Choki Dorji
    Pramote Tragulpiankit
    Arthorn Riewpaiboon
    Tashi Tobgay
    Drug Safety, 2016, 39 : 1239 - 1250
  • [44] Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers
    Chouchana, Laurent
    Canoui, Etienne
    Batista, Rui
    Contejean, Adrien
    Cariou, Alain
    Treluyer, Jean-Marc
    Charlier, Caroline
    THERAPIE, 2022, 77 (03): : 371 - 373
  • [45] Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey
    Dorji, Choki
    Tragulpiankit, Pramote
    Riewpaiboon, Arthorn
    Tobgay, Tashi
    DRUG SAFETY, 2016, 39 (12) : 1239 - 1250
  • [46] A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy
    Palladino, Raffaele
    Ceriotti, Daniele
    De Ambrosi, Damiano
    De Vito, Marta
    Farsoni, Marco
    Seminara, Giuseppina
    Barone-Adesi, Francesco
    VACCINES, 2021, 9 (06)
  • [47] Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
    Kale, Pratibha
    Gupta, Ekta
    Bihari, Chhagan
    Patel, Niharika
    Rooge, Sheetalnath
    Pandey, Amit
    Bajpai, Meenu
    Khillan, Vikas
    Chattopadhyay, Partha
    Devi, Priti
    Maurya, Ranjeet
    Jha, Neha
    Mehta, Priyanka
    Kumar, Manish
    Sharma, Pooja
    Saifi, Sheeba
    Swaminathan, Aparna
    Alam, Sarfaraz
    Uppili, Bharathram
    Faruq, Mohammed
    Agrawal, Anurag
    Pandey, Rajesh
    Sarin, Shiv Kumar
    VACCINES, 2022, 10 (01)
  • [48] Post ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (Covishield) Pulmonary Thromboembolism with Multiple Intracranial Ischemic Infarcts
    Jain, Rajendra S.
    Rao, Kaavya
    Sukhani, Paresh
    Pemawat, Ashish
    NEUROLOGY INDIA, 2022, 70 (03) : 1287 - 1288
  • [49] Immunological Response to ChAdOx1 nCoV-19 Vaccine among Health Care Workers at a Tertiary Care Hospital in Chennai
    Sneka, P.
    Hamsadwani, K. P.
    Sangamithra, V
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (01): : 578 - 584
  • [50] Adverse events following immunization associated with the ChAdOx1nCoV-19 and BBV152 vaccine-a cross-sectional study
    Prasad, T. S. Durga
    Gouru, Guna
    Vasuprada, S.
    Sandhya, B.
    Priya, D. S. Kavi
    Sudhakar, T.
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2023, 13 (03): : P76 - P83